Le Lézard
Classified in: Health, Business
Subjects: ACC, RCN

Capio Confirms Talks About Possible Structural Changes


GÖTEBORG, Sweden, June 24, 2018 /PRNewswire/ -- In response to market rumours, Capio confirms ongoing discussions relating to possible divestments of its non-Nordic operations.

Capio continuously evaluates different alternatives to drive growth and create shareholder value. As part of assessing several alternatives, Capio has been approached by potential buyers and has engaged in discussions concerning its non-Nordic operations.

With Capio's strong base in Modern Medicine and strategic direction towards specialization and digitalization, the board of directors of Capio sees it logical to evaluate these approaches in order to assess whether they are value creating for Capio's shareholders and reflect the full value of Capio's non-Nordic operations.

The board of directors of Capio believes a repositioning of Capio towards the Nordic markets has the potential to enhance the ability to deliver Capio's strategic focus on specialization and digitalization, thus driving shareholder value.

Capio will return with more information once available. Please note that no decisions have been made regarding potential structural changes. 

Contact:

Henrik Brehmer, Senior Vice President Group Communication & Public Affairs
Telephone: +46-761-11-34-14

This is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 00:20 (CET) on June 25, 2018. 

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/capio-ab/r/capio-confirms-talks-about-possible-structural-changes,c2556312

The following files are available for download:

http://mb.cision.com/Main/277/2556312/865702.pdf

PDF


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: